840 filings
8-K
CRDF
Cardiff Oncology Inc
21 Dec 20
Cardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of the Board
4:18pm
8-K
CRDF
Cardiff Oncology Inc
7 Dec 20
Cardiff Oncology Presents Data at ASH Demonstrating the Safety and Anti-Leukemic Activity of Onvansertib in Patients with Relapsed/Refractory AML
1:22pm
4
Vicki Kelemen
25 Nov 20
Cardiff Oncology / Vicki Kelemen ownership change
4:02pm
8-K
CRDF
Cardiff Oncology Inc
23 Nov 20
Cardiff Oncology to Participate in Fireside Chat at the Piper Sandler 32nd Annual Healthcare Conference
11:54am
8-K
CRDF
Cardiff Oncology Inc
5 Nov 20
Cardiff Oncology Announces Third Quarter 2020 Results and Highlights
4:09pm
SC 13G
bupzc9h 3w6idc2et
4 Nov 20
Cardiff Oncology / Venrock Healthcare Capital Partners III ownership change
4:54pm
8-K
njd0o
20 Oct 20
Cardiff Oncology Presents Positive Efficacy and Biomarker Data from mCRPC Trial Demonstrating Ability of Onvansertib to Overcome Zytiga® Resistance
11:59am
SC 13G
hahzcyhu7x
9 Oct 20
Cardiff Oncology / RA CAPITAL MANAGEMENT ownership change
4:29pm
3
27puugpd8
2 Oct 20
Cardiff Oncology / Rajeev M. Shah ownership change
4:30pm
8-K
dy5chzsapzg1ihjuqq
30 Sep 20
Cardiff Oncology Announces Proposed Public Offering
4:09pm
424B5
z93oc7v g2
30 Sep 20
Prospectus supplement for primary offering
4:00pm
424B5
6h2josq
29 Sep 20
Prospectus supplement for primary offering
4:00pm
8-K
87fc4f64yeqf71pho e4
22 Sep 20
Regulation FD Disclosure
12:00am
8-K
f3dx4o
17 Sep 20
Other Events
11:18am
4
vspu24mh
17 Sep 20
Cardiff Oncology / GARY W PACE ownership change
9:42am
8-K
6l4l4np5
15 Sep 20
Cardiff Oncology to Host Key Opinion Leader Call Discussing KRAS-Mutated Colorectal Cancer and Highlighting Data from Onvansertib Phase 1b/2 Trial
10:36am
8-K
ex3we4czw32b317ebk
14 Sep 20
Cardiff Oncology to Present Data Further Demonstrating the Safety and Efficacy of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer Patients
11:55am
SC 13G
5z0udskoru3nrnz fs
28 Aug 20
Cardiff Oncology / Opaleye Management ownership change
5:15pm
8-K
yb1707 sgxn54aucs
11 Aug 20
Cardiff Oncology Announces Second Quarter 2020 Results and Highlights
4:04pm